GLUT1 Inhibitor Remodels Tumor Microenvironment in Cholangiocarcinoma
A study in Cellular Oncology identifies GLUT1 as an immunometabolic regulator in intrahepatic cholangiocarcinoma, showing that its inhibition remodels the ...
A study in Cellular Oncology identifies GLUT1 as an immunometabolic regulator in intrahepatic cholangiocarcinoma, showing that its inhibition remodels the ...
A new study in Cancer & Metabolism demonstrates that combining untargeted metabolomics with machine learning can identify distinct metabolic signatures ...
A 2025 review in Cell Division details how heat shock factor 1 regulates cell division and drives tumorigenesis through metabolic ...
Hepatocellular carcinoma represents a widespread and aggressive malignancy characterized by poor prognosis, where the emergence of therapeutic resistance continues to ...
A new hypothesis in Clinical Epigenetics proposes that histone lactylation acts as an epigenetic memory code, linking metabolic reprogramming to ...
Researchers have identified that WDR54 drives head and neck squamous cell carcinoma progression by stabilizing the fatty acid transporter SLC43A3, ...
A review in Molecular Cancer outlines how liquid-liquid phase separation drives tumor evolution and provides programmable strategies for precision cancer ...
A review in Molecular Cancer examines how lactate and lysine lactylation regulate tumor biology, highlight challenges in establishing causality, and ...
A new study in Cell Division reveals that the long noncoding RNA LncPRESS1 promotes breast cancer progression and cisplatin resistance ...
A study in Cancer & Metabolism reveals that SENP1 drives de novo cholesterol synthesis in prostate cancer by deSUMOylating SREBP2, ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine